TABLE 1
FROM:
Treatment of primary IgA nephropathy
EFSTATHIOS ALEXOPOULOS Principal discussant:
BACK TO ARTICLETable 1. Clinical risk factors for progression in IgA nephropathy (IgAN)
| Impaired renal function at discoverya |
| Magnitude and duration of proteinuriaa |
| Hypertension at presentationb |
| Older age at onset |
| Absence of recurrent macrohematuria |
| Persistent microscopic hematuria |
| Male gender |
| Obesity |
| Hyperuricemia |
| Hypertriglyceridemia |
| Smoking |
| Familial disease |
a Most significant independent predictors by multivariate analysis in almost all studies (reviewed in8).
b Significant by univariate analysis in almost all studies and by multivariate analysis in some (reviewed in8).
